"Futa" inamaanisha nini?
Mnyama hana kubeba mabadiliko. Haitaendeleza ugonjwa huo na hataipitisha.
Centronuclear Myopathy (CNM) is a genetic disorder affecting Border Collies, characterized by muscle weakness and exercise intolerance. A DNA test for CNM is essential for responsible breeding, helping to identify carriers and reduce the risk of this debilitating condition. This simple yet effective test enables dog owners and breeders to make informed decisions, ensuring healthier puppies. By understanding the genetic predisposition to CNM, owners can provide better care and management for affected dogs. Regular screening through DNA testing not only promotes the health of individual dogs but also contributes to the overall well-being of the Border Collie breed. Invest in a CNM DNA test today to safeguard your canine companion’s future.
Centronuclear Myopathy (CNM) is a genetic disorder affecting Border Collies, characterized by muscle weakness and exercise intolerance. A DNA test can identify carriers and affected dogs, enabling breeders to make informed decisions to reduce the prevalence of this condition. Early detection through genetic testing can help owners manage symptoms and improve the quality of life for affected pets. Responsible breeding practices based on test results play a crucial role in preserving the health of the breed. Overall, DNA testing for CNM enhances breed welfare and promotes healthier generations of Border Collies.
Jaribio hili la DNA limejumuishwa kuanzia kwenye pakiti yetu Basic - na pia ni sehemu ya vifurushi Basic, Standard, Advanced, Complete.
Tazama Vifurushi vya Uchunguzi wa DNA →Centronuclear Myopathy (CNM) is a hereditary muscle disorder found in Border Collies. Characterized by weakness and muscle atrophy, this genetic condition significantly affects the dog's motor capabilities and overall quality of life. CNM results from mutations in specific genes leading to improper muscle fiber development and function.
Dogs affected by CNM typically exhibit clinical signs from a young age. Common symptoms include muscle weakness, reduced physical activity, exercise intolerance, abnormal gait, and muscle wasting. Severely affected dogs may have difficulty standing or walking, potentially impacting their ability to perform routine daily activities.
CNM in Border Collies is inherited in an autosomal recessive manner. This means a dog must inherit two copies of the mutated gene—one from each parent—to exhibit symptoms. Dogs carrying only one copy of the mutation (carriers) do not typically show signs but can pass the mutation onto offspring.
DNA testing is essential for identifying the CNM mutation in Border Collies. Early identification of affected and carrier dogs helps breeders make informed decisions, preventing the spread of the condition. DNA testing enables responsible breeding practices, assisting in reducing and eventually eliminating the occurrence of this debilitating condition.
The DNA test clearly distinguishes three genetic statuses:
Breeders are advised to conduct CNM DNA testing in breeding dogs before mating. Clear mating strategies should be selected to avoid producing affected puppies. Owners of Border Collies should consult veterinarians and genetic specialists for guidance on managing dogs diagnosed with CNM, ensuring the best possible quality of life.
Mnyama hana kubeba mabadiliko. Haitaendeleza ugonjwa huo na hataipitisha.
Hapana. Kwa ujumla mnyama huyo ana afya nzuri lakini anaweza kupitisha mabadiliko hayo uzao.
Inabeba nakala mbili zilizobadilishwa. Ishara za kliniki zinatarajiwa kulingana na ugonjwa huo. Haipaswi kufugwa.
Baadhi ya magonjwa yanahusishwa na ngono, hivyo kujieleza kwao hutofautiana kulingana na ngono ya mnyama.
This DNA test detects the mutation associated with Centronuclear Myopathy In Border Collie (CNM) in order to identify clear, carrier, or at-risk animals.
Upimaji wa DNA huwasaidia wafugaji kupanga uzazi salama na kupunguza hatari ya kusambaza mabadiliko hayo kwa watoto.
Hali ya urithi iliyoripotiwa kwa jaribio hili ni Autosomal Recessive.
This test analyses the mutation DNM2 c.1393C>T.
Si lazima. Ufafanuzi unategemea muundo wa urithi na genotype inayotokana.
Böhm Johann, Barthélémy Inès, Landwerlin Charlène, BlanchardGutton Nicolas, Relaix Frédéric, Blot Stéphane, Laporte Jocelyn, Tiret Laurent. A dog model for centronuclear myopathy carrying the most common DNM2 mutation. Dis Model Mech. 2022 Apr 1;15(4):dmm049219. doi: 10.1242/dmm.049219. Epub 2022 Apr 14.
Faragha yako, chaguo lako
Tunatumia vidakuzi muhimu kuendesha tovuti. Vidakuzi vya hiari (kama vile watoa huduma wa maudhui waliopachikwa) huzimwa kwa chaguomsingi na huwashwa tu ikiwa unakubali. Unaweza kubadilisha chaguo lako wakati wowote kwa kutumia kitufe cha "Vidakuzi".
Inahitajika kwa vipengele vya msingi na usalama. Imewashwa kila wakati.
Huboresha vipengele kama vile uwekaji mapendeleo au upachikaji usio wa utangazaji.
Inatusaidia kuelewa matumizi ya tovuti. Imezimwa kwa chaguomsingi.
Kutangaza/kufuatilia kwenye tovuti (baadhi ya vipachiko vya video/ramani). Imezimwa kwa chaguomsingi.